Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptors.
Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptors.
复制标题
DOI:
10.1021/jm2008562
复制
发表时间:
2011-10-13
影响因子:
7.3
通讯作者:
Kellam, Barrie
中科院分区:
文献类型:
--
作者:
Baker, Jillian G.;Adams, Luke A.;Salchow, Karolina;Mistry, Shailesh N.;Middleton, Richard J.;Hill, Stephen J.;Kellam, Barrie
The growing practice of exploiting noninvasive fluorescence-based techniques to study G protein-coupled receptor pharmacology at the single cell and single molecule level demands the availability of high-quality fluorescent ligands. To this end, this study evaluated a new series of red-emitting ligands for the human β-adrenoceptor family. Upon the basis of the orthosteric ligands propranolol, alprenolol, and pindolol, the synthesized linker-modified congeners were coupled to the commercially available fluorophore BODIPY 630/650-X. This yielded high-affinity β-adrenoceptor fluorescent ligands for both the propranolol and alprenolol derivatives; however, the pindolol-based products displayed lower affinity. A fluorescent diethylene glycol linked propranolol derivative (18a) had the highest affinity (log KD of −9.53 and −8.46 as an antagonist of functional β2- and β1-mediated responses, respectively). Imaging studies with this compound further confirmed that it can be employed to selectively label the human β2-adrenoceptor in single living cells, with receptor-associated binding prevented by preincubation with the nonfluorescent β2-selective antagonist 3-(isopropylamino)-1-[(7-methyl-4-indanyl)oxy]butan-2-ol (ICI 118551)
登录
查看更多内容
影响因子:
7.3
作者:
Hill, SJ
通讯作者:
Hill, SJ
DOI:
10.1124/jpet.104.082875
发表时间:
2005-06-01
影响因子:
3.5
作者:
Baker, JG
通讯作者:
Baker, JG
影响因子:
2.9
作者:
HEITHIER, H;HALLMANN, D;HELMREICH, EJM
通讯作者:
HELMREICH, EJM
影响因子:
3.6
作者:
Baker, JG;Hall, IP;Hill, SJ
通讯作者:
Hill, SJ
影响因子:
3.6
作者:
Baker, JG;Hall, IP;Hill, SJ
通讯作者:
Hill, SJ